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Cardiotrophin-1, a Cytokine Present
in Embryonic Muscle, Supports Long-Term Survival
of Spinal Motoneurons
D. Pennica,* V. Arce,† T. A. Swanson,* R. Vejsada,‡ As a first step toward identifying the factors involved,
R. A. Pollock,† M. Armanini,§ K. Dudley,† H. S. Phillips,§ different in vitro and in vivo systems have been devel-
A. Rosenthal,§ A. C. Kato,‡ and C. E. Henderson† oped in which motoneuron death can be reduced or
*Department of Molecular Biology prevented by the administration of exogenous factors
§Department of Neuroscience (for review, see Henderson et al., 1993a; Henderson,
Genentech Incorporated 1996). Molecules thus identified are candidate physio-
South San Francisco, California 94080 logical motoneuron survival factors and are also poten-
†INSERM Unite´ 382 tial therapeutic agents for slowing motoneuron death in
IBDM (CNRS–INSERM–Universite´ de la Me´diterrane´e) human diseases such as amyotrophic lateral sclerosis
Campus de Luminy (ALS) and the spinal muscular atrophies (SMA) (Hender-
13288 Marseille Cedex 09 son, 1995).
France Among the best-studied factors with neurotrophic ac-
‡Division of Clinical Neuromuscular Research tivity for motoneurons in a variety of experimental situa-
and Department of Pharmacology tions are the neurotrophins brain-derived neurotrophic
Centre Me´dical Universitaire factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin
1211 Geneva 4 4/5 (NT-4/5) (Oppenheim et al., 1992; Yan et al., 1992;
Switzerland Sendtner et al., 1992b; Henderson et al., 1993b; Vejsada
et al., 1995) and a transforming growth factor b family
member, glial cell line–derived neurotrophic factor
Summary (GDNF) (Henderson et al., 1994; Oppenheim et al., 1995;
Yan et al., 1995). They are all expressed in the peripheral
The muscle-derived factors required for survival of environment of the motoneuron during cell death (Hen-
embryonic motoneurons are not clearly identified. derson et al., 1993b, 1994). Moreover, motoneurons ex-
Cardiotrophin-1 (CT-1), a cytokine related to ciliary press high affinity receptors for BDNF, NT-3, and NT-4/5
neurotrophic factor (CNTF), is expressed at high levels throughout life (Henderson et al., 1993b). Nevertheless,
in embryonic limb bud and is secreted by differentiated definitive evidence for physiological involvement of
myotubes. In vitro, CT-1 kept 43% of purified E14 rat these factors in supporting motoneuron survival is cur-
motoneurons alive for 2 weeks (EC50 5 20 pM). In vivo, rently lacking. In the case of GDNF, no data are available
CT-1 protected neonatal sciatic motoneurons against concerning the nature of the GDNF receptor or the phe-
the effects of axotomy. CT-1 action on motoneurons notype of null-mutant mice. For the neurotrophins and
was inhibited by phosphatidylinositol-specific phos- their Trk receptors, no major loss of motoneurons is
pholipase C (PIPLC), suggesting that CT-1 may act
observed in either single or double knockout mice, at
through a GPI-linked component. Since no binding of
least on the C57/Bl6 genetic background that has been
CT-1 to CNTFRa was detected, CT-1 may use a novel
most thoroughly studied (see references in Henderson,
cytokine receptor a subunit. CT-1 may be important
1996), suggesting that neurotrophins may play a rolein normal motoneuron development and as a potential
in regulating motoneuron synaptogenesis or functiontool for slowing motoneuron degeneration in human
rather than survival.diseases.
The interleukin-6 (IL-6) family of cytokines are a group
of structurally related polypeptides including interleu-Introduction
kin-11 and oncostatin M that mediate their biological
effects through a closely linked family of receptorsPeripherally derived neurotrophic factors play a vital role
(Davis et al., 1993). Two members of this family, ciliaryin regulating the survival of spinal motoneurons at all
neurotrophic factor (CNTF) and leukemia inhibitory fac-stages of their development. When a limb is removed
tor (LIF), keep motoneurons alive when applied exoge-from a chick embryo before motor axons leave the spinal
nously in vitro and in vivo (Arakawa et al., 1990; Oppen-cord, all motoneurons destined to innervate that limb
heim et al., 1991; Martinou et al., 1992; Sendtner et al.,subsequently die during the normal cell death period
1992a; Henderson et al., 1994; Sagot et al., 1995; Vej-(Oppenheim, 1991; Hamburger, 1992). Axotomy of neo-
sada et al., 1995), and their receptors are known to benatal motoneurons in the spinal cord or brain stem re-
synthesized by motoneurons (Ip et al., 1993; Li et al.,sults in rapid death of all affected neurons (Sendtner et
1995b). Nevertheless, their physiological role in embry-al., 1990; Vejsada et al., 1995). In adult animals, axotomy
onic motoneuron survival has been thought to be mini-alone does not induce rapid motoneuron death. How-
mal, in part because levels of CNTF are extremely lowever, complete interruption of interactions with the pe-
before birth (Sto¨ckli et al., 1991; Ip et al., 1993), and inriphery by ventral root avulsion leads to loss of the oper-
part because mice in which the genes for CNTF, LIF, orated motoneurons over the following 6 weeks (Li et al.,
both are inactivateddo not show significant motoneuron1995a). The simplest explanation for these observations
loss during embryogenesis (Stewart et al., 1992; Escaryis that cells in the periphery that interact with the moto-
et al., 1993; Masu et al., 1993; Sendtner et al., 1996).neuron (and in particular skeletal muscle) produce neu-
Targeted disruption of gp130, a shared componentrotrophic factors that are required for motoneuron sur-
vival throughout the life of the organism. of the CNTF receptor (CNTFR) and LIF receptor (LIFR)
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complexes, leads to myocardial disorders, but the neu-
ronal phenotype is unknown (Yoshida et al., 1996). Re-
cently,however, it has beenreported that knockout mice
for either the a subunit of the CNTFR (DeChiara et al.,
1995) or the b subunit of the transmembrane LIFR (com-
mon to both receptor complexes) (Li et al., 1995b) die
shortly after birth. In contrast with null mutants for the
corresponding factors, both receptor mutants show a
loss of approximately 40% of motoneurons in spinal
cord and brain stem. These results suggest that an un-
identified ligand of the CNTFR and/or LIFR plays a physi-
ological role in regulating motoneuron survival in vivo.
Recently, a novel member of the IL-6 family of cyto-
kines, called cardiotrophin-1 (CT-1), was identified and
cloned based on its ability to induce hypertrophy in
cultured neonatal cardiac myocytes (Pennica et al.,
1995a). In the presence of gp130, CT-1 binds to the
LIFRb subunit with an affinity in the nanomolar range,
in a competitive manner with LIF (Pennica et al., 1995b).
Like CNTF, CT-1 has no signal peptide but is secreted
by transfected cells in vitro (Pennica et al., 1995a). In
addition to its hypertrophic activity, it also enhances
survival and maturation of different neuronal popula-
tions in culture (Pennica et al., 1995b). Here, we show
that CT-1 can provide long-term support to a fraction
of motoneurons very similar to that lost in the CNTFR
and LIFR knockout mice and that its expression pattern
is consistent with a role as a target-derived neurotrophic
factor during normal motoneuron development.
Results
Cardiotrophin-1 mRNA Is Present in the
Environment of the Embryonic Motoneuron
To determine whether cardiotrophin-1 might be avail-
able to developing motoneurons, CT-1 mRNA expres-
sion was analyzed by in situ hybridization during the
period of motoneuron cell death. At embryonic day 13.5
(E13.5) in the mouse, the stage at which motoneuron
death is about to begin, there was a strong signal for
Figure 1. Levels of CT-1 mRNA Are High in Embryonic Limb BudCT-1 mRNA in several peripheral tissues, with particu-
but Decrease during the Period of Naturally Occurring Motoneuron
larly high concentrations in developing limb bud (Figure Death
1A). Only weak hybridization to spinal cord and other (A) Cross section of an E13.5 mouse embryo after in situ hybridiza-
central nervous system structures was observed. No tion for CT-1 mRNA. Note the strong signal in distal limb bud.
signal was observed when an adjacent section was hy- (B) In situ hybridization on a longitudinal section of an E15.5 embryo.
Only low levels of CT-1 mRNA are apparent in the central nervousbridized with a sense probe (data not shown). At E15.5,
system.a similar pattern was observed, together with strong
(C) Semiquantitative RT–PCR to compare levels of CT-1 mRNA inlabeling of bone structures (Figure 1B). After the period
limb bud at E14.5 and PN1. Amplified fragments obtained by PCR
of motoneuron cell death, on postnatal day 1 (PN1), no using primers for GAPDH or CT-1 on mRNA samples incubated with
specific signal could be detected on any structure in (RT1) or without (RT2) reverse transcriptase were stained with EtBr.
the limb bud by in situ hybridization (data not shown).
In parallel experiments using a probe for mouse LIF, no
specific signal was detected at either E13.5 or PN1 (data ure 1C), the amplified fragment (281 bp) hybridized to
a specific internal oligonucleotide (data not shown). Anot shown).
We used semiquantitative reverse transcriptase– strong CT-1 signal was obtained using E14.5 limb bud
(Figure 1C). However, in agreement with our results frompolymerase chain reaction (RT–PCR) to compare levels
of CT-1 in limb bud at the beginning and the end of the insitu hybridization, levels of CT-1 mRNA were mark-
edly reduced by the end of cell death (Figure 1C).the motoneuron cell death period. Samples of cDNA
prepared from total limb bud of E14.5 mouse embryos These results suggest that CT-1 may be available to
motoneurons at high levels as competition for muscle-and PN1 mouse pups were normalized for GAPDH
mRNA (Figure 1C). When RT–PCR was performed on derived trophic support begins, and that subsequently
only lower levels of this factor may be present.the same samples using primers specific for CT-1 (Fig-
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Figure 2. Muscle Cells Express mRNA for
CT-1 and Secrete Mature CT-1 Protein
(A) Total RNA from the indicated cells was
reverse transcribed and amplified using spe-
cific primer pairs for mouse CT-1. All muscle
cells expressed high levels of CT-1 mRNA,
whereas neither C6 glioma nor purified moto-
neurons had detectable levels. A plus or mi-
nus sign indicates with or without reverse
transcriptase, respectively.
(B) Western blots of recombinant mouse CT-1
(CT-1), complete culture medium (CCM), and
medium conditioned by C2/C7 myotubes
(C2/C7) stained using an affinity-purified anti-
body to CT-1. Specific immunoreactivity was
only observed at an apparent molecular mass
of 30 kDa.
Cardiotrophin-1 Is Synthesized and Secreted CT-1 Is a Potent Long-Term Survival Factor
for a Fraction of Purified Motoneuronsby Differentiated Myotubes
The high levels of expression in several different periph- Using the culture system for purified motoneurons we
previously described (Henderson et al., 1995), we testederal tissues suggested that the target tissue of motoneu-
rons, skeletal muscle, was a potential source of CT-1. the ability of CT-1 to enhance motoneuron survival over
3 days in culture. Like CNTF and LIF (Henderson et al.,We therefore used RT–PCR to detect synthesis of CT-1
mRNA by immortalized muscle cell lines (primary myo- 1994), 10 ng/ml CT-1 supported z50% of motoneurons
that initially developed in culture (data not shown). Totube cultures from rodent arecontaminated by Schwann
cells and fibroblasts and so were not used). Cultures of better analyze the trophic effects of CT-1, we developed
a new long-term culture system for these highly purifiedundifferentiated myoblasts and differentiated myotubes
were prepared from three different muscle cell lines: C2/ motoneurons, based on the use of Neurobasal medium
with the B27 supplement (see Experimental Proce-C7 (Catala et al., 1995), Sol8 (Pinset et al., 1991), and
129CB3 (Pinc¸on-Raymond et al., 1991; data not shown). dures). All neurons analyzed in this study were large,
multipolar neurons that expressed Islet-1/2, an indepen-CT-1 mRNA was detected in all muscle sources, but
was absent from C6 glioma cells, used as a control dent marker for spinal motoneurons (Henderson et al.,
1994; Tsuchida et al., 1994).(Figure 2A). Furthermore, in agreement with our in situ
hybridization results, no CT-1 mRNA could be detected The potency of CT-1 action was determined by direct
counting of motoneuron survival in the presence of in-in purified motoneurons (Figure 2A).
Like CNTF, CT-1 does not have a consensus signal creasing concentrations of CT-1; a dose-response curve
after 6 days of culture in Neurobasal medium is shownpeptide. To confirm that CT-1 could nevertheless be
released by muscle cells into their environment, we per- in Figure 3. The mean value for the EC50 was 550 pg/
ml, or 2 3 10211 M, as calculated from three differentformed Western blots on samples of conditioned me-
dium from differentiated C2/C7 myotubes. Purified re- experiments in which survival times ranged from 3 to
10 days. This is similar to the values we have reportedcombinant muCT-1 produced in human 293 cells
(derived from embryonic kidney) migrated with an ap- for rat CNTF in short-term culture (Martinou et al., 1992;
Henderson et al., 1994).parent molecular weight of 30 kDa, corresponding to a
glycosylated form of the 22 kDa polypeptide (Figure 2B). Using the possibilities for long-term analysis provided
by Neurobasal medium, we cultured motoneurons in theUsing affinity-purified rabbit polyclonal antibodies to
muCT-1, we detected a band at 30 kDa inmedium condi- presence and absence of CT-1 for periods up to 16 days
in vitro. Even at low density, motoneurons survived andtioned by C2/C7 myotubes, but not in unconditioned
medium (Figure 2B). By comparing the intensity of the matured in these conditions to a remarkable degree. In
the presence of CT-1, motoneurons developed rapidlyband on the Western blot with that obtained using differ-
ent quantities of recombinant CT-1 (data not shown), in culture and after 3 days had developed long axons
and multipolar morphology (Figure4A). After longer peri-we estimate that myotube-conditioned medium con-
tains approximately 1–5 ng/ml CT-1. Thus, CT-1 is se- ods in the presence of CT-1, morphological develop-
ment of motoneurons was even more pronounced. Atcreted at biologically significant levels by healthy differ-
entiated myotubes in culture. 9–11 days of culture, surviving neurons showed a highly
Neuron
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Figure 3. Dose-Response Curve for the Survival-Promoting Effect
of CT-1 on Purified E14 Motoneurons after 6 Days in Culture
Values are expressed relative to the number of motoneurons surviv-
ing in 100 pg/ml GDNF, determined after 16 hr of culture and taken
as 100%. Mean values (6SEM) for triplicate dishes are shown. Cal-
culated EC50 for this curve was 450 pg/ml.
multipolar morphology (Figure 4B), with axon-like pro-
cesses often several millimeters in length (Figure 4C)
and tapering, thick dendrite-like processes with many
secondary branches (Figure 4D). The theoretical age of
E14 motoneurons cultured for 11 days was postnatal
day 4; their morphology suggests that many aspects
of their maturation occurred normally in culture in the
presence of CT-1.
Despite theobviously healthy appearance of surviving
motoneurons, optimal concentrations of CT-1 were not
capable of maintaining all motoneurons in the long term.
In six independent experiments counted between 9 days
and 16 days of culture, the fraction of motoneurons
surviving in the presence of CT-1 was 43% 6 1%. The
corresponding value for cultures without trophic factor
was 6% 6 2% (n 5 6). In the same experiments, GDNF,
themost potentsurvival factor for motoneurons in short-
term culture (Henderson et al., 1994), maintained only
24% 6 6% (n 5 6) of motoneurons that initially devel-
oped in culture. The number of surviving motoneurons
was not increased when different concentrations of
CT-1 or GDNF, or different regimens for medium replen-
ishment, were tested (data not shown). These values
therefore seem to represent characteristic fractions of Figure 4. Purified E14 Motoneurons Grown in the Presence of 10
ng/ml CT-1 for Different Periodsmotoneurons kept alive by single neurotrophic factors.
(A) Motoneuron after 3 days in culture. Note multipolar morphology,
with limited branching.
(B) Motoneuron cultured for 9 days with CT-1, and stained for neuro-
filament. Each motoneuron has several primary neurites and in-(D) Motoneuron cultured for 11 days in CT-1. The asymmetric soma
creased branching.andthick tapering dendrites with many smaller processes are typical
(C) Low power view of same culture as (B). Only 2 cell bodies areof motoneurons in these long-term cultures. Scale bars: shown in
visible in this field (arrowheads). Note extensive neurite network.(A), 50 mm for (A), (B), and (D); shown in (C), 100 mm for (C).
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We compared the capacity of three cytokines of the
IL-6 subfamily, CT-1, CNTF, and LIF, to support long-
term survival. In 14 experiments in which identical con-
centrations (10 or 100 ng/ml, depending on the experi-
ment) of mouse CT-1, rat CNTF, or mouse LIF were
assayed in parallel, the numbers of motoneurons kept
alive by each factor, expressed relative to CT-1, were
100% (CT-1), 93% 6 6% (CNTF), and 80% 6 6% (LIF).
When optimal concentrations of different pairs of cyto-
kines were assayed in combination, the number of sur-
viving motoneurons did not increase (data not shown).
Therefore, many of the same motoneurons that respond
to CT-1 are also kept alive in culture by CNTF or LIF.
Our in vitro results therefore suggest that a character-
istic fraction (z45%) of motoneurons survive and mature
in the presence of cytokines, in particular the muscle-
derived cytokine CT-1. Interestingly, CT-1 alone is 80%
more efficacious than GDNF in this system.
CT-1 Protects Motoneurons against the
Figure 5. A Single Application of CT-1 Has Long-Term Protective
Effects of Neonatal Axotomy In Vivo Effects on Survival of Axotomized Neonatal Sciatic Motoneurons
To confirm that the neurotrophic actions of CT-1 were The time course of motoneuron survival in the presence (closed
not limited to cultured neurons, we tested its ability to circles) or absence (open squares) of 1.5 mg/ml CT-1. The neuro-
protect neonatal rat motoneurons in vivo. Sciatic nerves trophic factor (together with Fluorogold) was applied to the central
stump of the cut sciatic nerve in 2-day-old rats. The number ofof rat pups were sectioned on postnatal day 2, and a
motoneurons was determined 1, 2 or 3 weeks later. Motoneuroncupule containing a Fluorogold tracer plus the factor to
counts are expressed as mean 6 SEM.be tested was applied directly to the nerve stump; 1, 2,
and 3 weeks later, the rats were sacrificed, and the
in vivo, raised thepossibility that CT-1 might be a physio-surviving fluorescently labeled motoneurons were
logical survival factor for embryonic motoneurons. Twocounted on the operated side.
cytokine receptor subunits, LIFRb and CNTFRa, wereThe initial number of sciatic motoneurons in the new-
recently shown to be essential for the survival of moto-born rat was determined by applying Fluorogold alone
neurons in knockout mice (DeChiara et al., 1995; Li etto the cut sciatic nerve and sacrificing the rats 60–70
al., 1995b). We therefore designed experiments to testhr later; the value thus obtained was 1385 6 150 (n 5
the hypothesis that CT-1 might be the physiological4). A majority of these motoneurons had died by 1 week
ligand for these receptors.after axotomy: only 449 6 74 (n 5 5) motoneurons were
One characteristic property of the CNTFR complex ismaintained in vehicle-treated animals, indicating that
the presence of the GPI-linked CNTFRa subunit. As aapproximately 936 cells had degenerated.
first step toward testing the possibility that CT-1 mightWhenanimals were treated with CT-1 at 0.7 mg/ml, the
act through the CNTFR complex, we tested the capac-number of motoneurons determined at 1 week (884 6
ity of phosphatidylinositol-specific phospholipase C47, n 5 6) was significantly greater than in controls.
(PIPLC) to inhibit the CT-1 survival response. PIPLC canTherefore, application of CT-1 can rescue about 46%
specifically cleave the GPI linkage that attaches certainof the cells that would normally have died during this
molecules to the surface of living cells (Low et al., 1986).period. The short-term rescue effects of CT-1 were very
Purified motoneurons in suspension were treated insimilar to those of LIF at this same concentration (883 6
complete culture medium for 2 hr at 378C with 1–2 mg/ml164, n 5 3). Furthermore, the efficacy of CT-1 was not
PIPLC (or an equivalent volume of phosphate-bufferedsignificantly changed when applied at 0.3, 0.7, or 1.5
saline [PBS]) before being seeded in 16 mm wells in themg/ml.
presence or absence of different trophic factors. PIPLCAs with all other neurotrophic factors tested using this
was replaced in appropriate wells at 1–2 mg/ml at 0 hrprotocol (Vejsada et al., 1995), protection afforded by
and 14 hr of culture; motoneuron survival was quantifieda single dose of CT-1 decreased with time (Figure 5).
after 24–48 hr (Figures 6A and 6B). As expected, moto-Nonetheless, a supramaximal dose of 1.5 mg/ml caused
neuron survival in basal medium or in the presence ofa significant rescue of motoneurons above the control
1 ng/ml BDNF, which acts through the transmembranelevels at 1, 2, and 3 weeks. These long-term partial
TrkB receptor, did not differ significantly betweensurvival effects obtained with CT-1 have never been
PIPLC-treated and control motoneurons (in six indepen-observed with CNTF or LIF (Vejsada et al., 1995).
dent experiments, the mean number of PIPLC-treated
motoneurons that survived in1 ng/ml BDNF was 107% 6
6% of the number of untreated motoneurons). PIPLC isThe CT-1 Receptor on Motoneurons
Has a GPI-Linked Component not therefore toxic for motoneurons at this concentra-
tion (similar results were obtained using 5 mg/ml PIPLC;The secretion of CT-1 by embryonic muscle, and its
potent neurotrophic activity onmotoneurons in vitro and data not shown).
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Figure 6. CT-1 Action on Motoneurons Re-
quires a GPI-Linked Component
Purified motoneurons were preincubated
with PIPLC (striped bars) or with PBS (stip-
pled bars) and then seeded in the presence of
the indicated concentrations of neurotrophic
factors.
(A) PIPLC was used at 1 mg/ml and motoneu-
ron survival was counted after 30 hr.
(B) In an independent experiment, PIPLC was
used at 2 mg/ml and higher concentrations of
neurotrophic factor were applied. To facilitate
comparison, survival values were corrected
for basal survival in Neurobasal medium in
the corresponding experiment; they are ex-
pressed as the mean 6 SEM of four counts
in two independent wells.
Subsequently, the survival response in the presence expression cloning: both LIF and CT-1 induce myocyte
hypertrophy, whereas CNTF has little or no activity (Pen-of different cytokines was tested (Figure 6A). The num-
nica et al., 1995a). This difference in activity is presum-ber of motoneurons surviving in 10 ng/ml LIF remained
ably due to the lack of expression of CNTFRa on myo-unchanged after treatment with 1 mg/ml PIPLC, whereas
cytes. When CNTF was added to cardiac myocytesthe response to 10 ng/ml CNTF was decreased as ex-
alone, no hypertrophy was observed. However, whenpected. Strikingly, the response to 10 ng/ml CT-1 was
the same concentration of CNTF was added in the pres-reduced to the same extent (Figure 6A). In subsequent
ence of 25 nM or 50 nM sCNTFR, then hypertrophy wasexperiments, PIPLC was used at 2 mg/ml: even greater
close to maximal (scores 6.0 and 6.5, respectively) andreductions in CNTF- and CT-1-dependent survival were
similar to that reported for LIF and CT-1 (Figure 7A).observed, even when cytokines were applied at 50 ng/
Thus, the purified sCNTFR was biologically active andml (Figure 6B). On average (n 5 3), the ratios of the
allowed CNTF to signal through the LIFR complex asnumbers of surviving motoneurons in the presence and
previously described (Davis et al., 1993).absence of 2 mg/ml PIPLC were 112% 6 23% (LIF),
We first tested the ability of CT-1 to bind directly to20% 6 3% (CNTF), and 23% 6 8% (CT-1).
sCNTFRa. 125I-labeled CT-1 (0.7 nM) was incubated withThese data show that a GPI-linked component is re-
sCNTFRa (40 nM) for 2 hr at room temperature, and anyquired for CT-1 action in this system. This component
complexes formed were captured using nickel agarosemay contribute to the CT-1 receptor complex in a man-
beads. No specific binding could be detected (data notner analogous to that of the CNTFRa to the CNTFR
shown). Using an identical protocol, strong specificcomplex. The incomplete loss of CT-1 sensitivity in
binding of labeled CT-1 to sLIFR, and of labeled CNTF toPIPLC-treated motoneurons may reflect incomplete ac-
sCNTFRa, were observed as expected, demonstratingcess of PIPLC to the GPI linkage, as suggested by the
that all components were functional (data not shown).greater effect observed using 2 mg/ml PIPLC (Figures
To exclude the possibility that CT-1 bound to sCNTFRa6A and 6B), or action of CT-1 through the residual LIFR
might be lost during precipitation of the complex, westill present on these cells (Pennica et al., 1995b).
performed incubations of labeled CT-1 with sCNTFRa
or sLIFR in the same conditions, except that after 2 hr
CT-1 Is Not a Ligand for the CNTFRa Subunit the cross-linker 1-ethyl-3-(3-dimethylaminopropyl) car-
Since CT-1 is related to CNTF, an obvious candidate for bodiimide/N-hydroxysulfosuccinimide (EDC/sulfo-NHS)
the putative GPI-linked component revealed by PIPLC was added for 30 min. After analysis by SDS–PAGE, no
treatment was the CNTFRa subunit, the GPI-linked sub- cross-linking of CT-1 to sCNTFRa could be detected,
unit that is necessary for signaling through the gp130/ whereas CT-1 and sLIFR gave a radioactive cross-linked
LIFR complex. We therefore directly examined, by sev- product of the appropriate size that disappeared when
eral methods, the ability of CT-1 to bind this subunit. the incubation was performed in the presence of 1 mM
A soluble form of the rat CNTFR (sCNTFR) was ex- unlabeled CT-1, but remained in the presence of 1 mM
pressed as its extracellular domain containing a car- unlabeled CNTF (data not shown).
boxy-terminal histidine tag and purified by chelate chro- Since we could detect no direct binding of CT-1 to
matography (see Experimental Procedures). To confirm sCNTFRa, we used functional assays to detect possible
that the recombinant sCNTFRa was biologically active, interactions between them. First, the hypertrophy of car-
we assessed its ability to cause hypertrophy of neonatal diac myocytes was assayed in the presence of different
cardiac myocytes in the presence of its ligand. This CT-1 concentrations ranging from 1 pM (no hypertrophy)
to 200 pM (near-maximal hypertrophy). No change inhypertrophy assay was originally used to isolate CT-1 by
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any of the hypertrophy scores was observed when the
same CT-1 concentrations were tested in the presence
of biologically activeconcentrations of sCNTFRa (Figure
7B). Thus, the hypertrophy response of the myocytes
to CT-1 is not potentiated by sCNTFRa.
A further demonstration of the inability of sCNTFRa
to facilitate CT-1 action was provided by analysis of
purified motoneurons treated with PIPLC. As described
above, PIPLC-treated motoneurons responded only
poorly to 50 ng/ml CNTF (Figure 7C). However, in the
presence of 25 nM sCNTFRa, the CNTF response of
PIPLC-treated motoneurons was completely reconstitu-
ted. In contrast, sCNTFRa caused no increase in the
response of PIPLC-treated motoneurons to CT-1, al-
though motoneurons treated with PIPLC and CT-1 were
still capable of a normal response to LIF (Figure 7C).
sCNTFRa itself had no effect on the response to LIF
(Figure 7C). Therefore, even in the specific environment
of the motoneuron membrane, sCNTFRa cannot medi-
ate interactions of CT-1 with the LIFR complex.
It remained possible that CT-1 exerted its biological
effects through CNTFRa, but was unable to interact
functionally with the soluble form of the receptor. We
therefore tested the ability of CT-1 to compete for the
binding of radiolabeled CNTF to the rat adrenal pheo-
chromocytoma PC12 cell line (Figure 8A). These cells
have been reported to bind CNTF and form a binding
complex composed of ligand, CNTFRa and gp130
(Wong et al., 1995). Excess unlabeled CNTF reduced
binding of radiolabeled CNTF on PC12 cells to back-
ground levels. In contrast, CT-1 and LIF were unable to
compete for CNTF binding even at a 1000-fold molar
excess (Figure 8A). Similar results were obtained using
human 293 cells (Figure 8B). Furthermore, binding of
radiolabeled CT-1 to M1 cells was reduced to back-
ground levels by incubation with unlabeled CT-1 or LIF,
but was only partially affected by incubation with unla-
beled CNTF (Figure 8C). Whereas treatment of PC12
and 293 cells with PIPLC significantly reduced CNTF
binding (Figures 8A and 8B), binding of CT-1 to M1 cells
was not affected by PIPLC (Figure 8C). In agreement
with this, PIPLC treatment did not affect the hypertro-
phic activity of CT-1 for cardiac myocytes (data not
shown).
Taken together, these data suggest that CT-1 is not
a ligand for the CNTFRa subunit. The GPI-linked compo-
nent of the CT-1 receptor complex on motoneurons may
therefore be a novel cytokine receptor subunit.
Discussion
Our results make cardiotrophin-1 a strong candidate as
a physiological motoneuron survival factor. It supports
Figure 7. Soluble CNTFRa Can Mediate the Actions of CNTF on (C) Motoneuron survival values (corrected for those in basal medium)
Myocytes and Motoneurons, but Does Not Potentiate CT-1 Action after 52 hr of culture in the presence of indicated substances. Neuro-
(A and B) Hypertrophic effects on neonatal rat ventricular myocytes trophic factors were used at: 1 ng/ml (BDNF), 50 ng/ml (LIF, CNTF,
of CNTF (A) or CT-1 (B) tested alone at indicated concentrations and CT-1). PIPLC was used at 2 mg/ml as described in the text.
(stippled bars) or in the presence of 25 nM sCNTFRa (closed bars). Soluble CNTFRa (25 nM) reconstituted the effect of CNTF, but not
A score of 3 is no hypertrophy; 7 is maximal hypertrophy. Note that of CT-1. Values are mean 6 SEM of four counts in two independent
the dose-response for CT-1 is not displaced by sCNTFRa. wells.
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Figure 8. Competition between Cytokines for Their Binding Sites
Rat PC12 cells (A), human kidney 293 cells (B), and mouse M1 cells (C). [125I]rCNTF (A and B) and [125I]mCT-1 (C) were incubated in duplicate
with PC-12 cells (4 3 106 cells per reaction), 293 cells (5 3 106 cells), and M1 (10 3 106 cells) in the presence of a 1000-fold molar excess of
the indicated competitors as described in Experimental Procedures. The same experiments were performed in each case with untreated cells
(stippled bars) and cells preincubated with 2 mg/ml PIPLC (closed bars). Results are the mean 6 range of two reactions.
the survival and maturation of a discrete fraction of mo- Could CT-1 be the physiological ligand for the CNTFR
and LIFR, which are known to be required for survivaltoneurons on a long-term basis, is synthesized and se-
creted by embryonic muscle, and can keep lesioned of some embryonic motoneurons? Our data clearly dem-
onstrate that a component of the receptor or signalingmotoneurons alive in vivo. Furthermore, it binds to the
LIFRb subunit, which is expressed by embryonic moto- system for CT-1 at the surface of cultured motoneurons
is sensitive to PIPLC, under conditions in which thisneurons and is known to be necessary for the survival
of a significant fraction of them. enzyme shows no nonspecific toxicity (Figure 6). Since
the response to CNTF, but not to LIF, is also affectedCNTFR and LIFR knockout mice show a similar extent
of motoneuron loss at birth (33% and 43% in lumbar by PIPLC, it is probable that the CT-1 receptor, like the
CNTFR, has an essential GPI-linked component. Usingspinal cord, 41%and 37%in facialnucleus, respectively)
(DeChiara et al., 1995; Li et al., 1995b). It is indeed possi- a variety of approaches, we were unable to detect bind-
ing of CT-1 to the CNTFRa subunit (Figures 7 and 8).ble that the same motoneurons are lost in each mutant.
Although prudence is required in comparing in vivo and Although we cannot completely rule out the possibility
that CT-1 can act through CNTFRa in the specific envi-in vitro data, it is striking that the percentages of moto-
neurons that survive in the presence of CT-1 in our long- ronment of the motoneuron membrane, the simplest
hypothesis would be that CT-1 action requires a novelterm cultures (43%) and in vivo after axotomy (46%)
are very similar to the fraction lost in CNTFR and LIFR GPI-linked a subunit. Our tentative conclusion, there-
fore, is that the cytokine whose existence is implied byknockout mice. Moreover, in short-term cultures of mo-
toneurons, CNTF has been reported to support approxi- motoneuron loss in the CNTFR knockout mice is not
CT-1. Interestingly, binding of CT-1 to non-neuronalmately half of the total population (Arakawa et al., 1990;
Martinou et al., 1992; Henderson et al., 1994). In all these cells expressing LIFR is not PIPLC-sensitive, and PIPLC
treatment did not reduce the ability of CT-1 to induceexperimental systems, motoneuron death is continuing
(at least at a reduced rate) at the time at which survival cardiac myocyte hypertrophy. These data suggest that
the novel GPI-linked component may not be present onis estimated. It would therefore be inappropriate to attri-
bute too great a significance to the absolute value of all CT-1-responsive cell types. Further analysis of the
physiological role of CT-1 in the spinal cord will involve45%. Nevertheless, the data are consistent with the idea
that a discrete subpopulation of motoneurons is capable identification of the GPI-linked component, as well as
inactivation of the CT-1 gene itself.of responding to cytokines and requires them for sur-
vival.Most motoneurons in this population must express Consistent with a role in regulating motoneuron num-
bers during development, levels of CT-1 mRNA are highboth CNTFRa and LIFRb subunits since, using E14 rat
motoneurons, optimal concentrations of CNTF gave in limb bud at the beginning of cell death and subse-
quently fall off steeply (Figure 1). Similar developmentalsimilar long-term survival values to LIF, and combina-
tions of different cytokines did not further increase sur- regulation was reported for levels of LIF mRNA, which
fall rapidly between E17 and birth in mouse hind legvival. It is not known whether only a fraction of motoneu-
rons insitu express different components of thecytokine muscles (Kwon et al., 1995). Using an antiserum to CT-1,
Sheng et al. (1996) recently described high levels of CT-1receptor complex. It will thus be important to determine
whether cytokine-responsive motoneurons differ from protein at E15.5 in skeletal muscle, the target tissue of
motoneurons, but didnot compare levels at later stages.other motoneurons in this respect, or in terms of other
markers involved in signaling and survival. The presence of CT-1 mRNA in adult skeletal muscle
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described (Melton et al., 1984). Simultaneous hybridization with twohas been demonstrated by Northern blots in both mouse
probes to different regions of CT-1 mRNA was performed. The pairs(Pennica et al., 1995a) and human (Pennica et al., 1996).
of sense and antisense probes were synthesized from cloned 161We used immortalized cell lines to demonstrate that
bp and 188 bp cDNA fragments (nucleotides 20–180 and 645–832,
newly formed myotubes synthesize high levels of CT-1 respectively; Pennica et al., 1995a) using T7 polymerase.
mRNA. GDNF, another factor thought to play a role in
motoneuron development is predominantly expressed
cDNA Preparationin Schwann cells at E14.5 (although GDNF mRNA ap-
Total RNA was isolated using the Trizol reagent (GIBCO-BRL). Apears in muscle at later stages) (Henderson et al., 1994;
sample of each RNA was treated for 2 hr with RNase-free DNase I
Trupp et al., 1995). It is possible that CT-1 and GDNF (Boehringer Mannheim) and then extracted with Trizol and precipi-
may interact to promote the survival of motoneurons in tated with isopropanol. Pellets were taken up in 48 ml of reverse
transcriptase mix containing the following: 200 mM dNTP mix (Phar-vivo; the potential mechanisms of this interaction are
macia), 10 mM DTT, 0.5 mg of oligo(dT) (GIBCO-BRL), 13 reactioncurrently under study.
buffer (GIBCO-BRL). Reactions were incubated for 10 min at 708C,The absence of a conventional signal peptide in the
chilled on ice, and divided into two aliquots, one of which receivedCNTF molecule initially led to the hypothesis that it may
400 U of Superscript II (GIBCO-BRL), the other serving as the RT-
serve as a “lesion” factor, to be released upon injury negative control. Both aliquots were incubated at 428C for 1 hr.
(Sendtner et al., 1990). Although evidence for this hy-
pothesis has not been forthcoming, it was important to
PCR Reactionsdemonstrate that CT-1, which also lacks a signal pep-
To normalize the levels of each cDNA, control GAPDHPCR reactionstide, can be secreted by muscle cells and thereby be-
were carried out for 27 cycles as described (Henderson et al., 1994).
come potentially available to the motoneuron. Using an PCR reactions for CT-1 cDNA (34 cycles) were then performed in a
affinity-purified polyclonal antibody to CT-1, we de- final volume of 50 ml containing the following: 1 mg of each primer,
200 mM dNTP mix, 60 mM Tris–HCl (pH 9.5), 15 mM (NH4)2SO4, 1.5tected a 30 kDa species corresponding to mature CT-1
mM MgCl2, 0.05% W-1 (GIBCO-BRL), and 1 U of Taq DNA polymer-in the supernatant of healthy cultures of C2/C7 myo-
ase (GIBCO-BRL). The following specific primers were used: forwardtubes. No dying cells were microscopically apparent in
primer CGGCCAACAGCACTGCAGGCATC (nucleotides 504–526 ofthese cultures, and thus the CT-1 is unlikely to have
the mouse CT-1 cDNA sequence; GenBank accession number
been released by cell lysis. Furthermore, the estimated U18366); reverse primer AAGCTCCCTGCAGAGAGGAGAGC (nucle-
levels of CT-1 (1–5 ng/ml) are consistent with the idea otides 785–763); and internal probe for Southern blots GTCGCCCTC
TGTGCGGCTCACCCACTC (nucleotides 598–572). PCR productsthat it may be a major contributor to the trophic activity
were electrophoresed on a 6% acrylamide gel, and the results wereof myotube-conditioned media. This provides direct evi-
analyzed by EtBr staining. After electroblotting, all amplified frag-dence for secretion of a potential neurotrophic factor
ments hybridized strongly to the internal probe (data not shown).for motoneurons by their target tissue, skeletal muscle.
We used an experimental model of motoneuron de-
generation in vivo to show that, like other cytokines of Detection of CT-1 on Western Blots
Cell culture supernatants were concentrated by centrifugationthis family, CT-1 can significantly reduce motoneuron
through Centricon membranes and loaded onto 10% polyacryl-death brought about by neonatal axotomy. These results
amide gels. Pure recombinant CT-1 was used as a marker togethermake CT-1 an important addition to the list of neuro-
with Amersham Rainbow markers. After electrophoresis, gels were
trophic factors that may potentially be of use in slowing blotted onto nitrocellulose membranes and stained with Ponceau
pathologic motoneuron loss in humans, but several Red. Since the primary antibody showed some reaction with the
high levels of serum albumin present in the conditioned media,points remain to be addressed. First, since CT-1 is a
membranes were cut just below the albumin band at 66 kDa, andcytokine with actions in other tissues such as heart (Pen-
only the lower part processed for CT-1 immunoreactivity. Prior tonica et al., 1995a) and liver (Peters et al., 1995), it will
addition of antibody, membranes were prehybridized in 1% nonfatbe necessary to limit potential side effects by localized
milk, 5% goat serum for 30min. Affinity-purified anti-CT-1 antibodies
delivery. Second, the “rescue” effect described here (3 mg/ml) were added in the prehybridization solution and incubated
decreases after the first week following axotomy. It is at 258C for 1 hr. The membranes were washed three times with PBS
containing 0.5% Tween 20 before addition of a 1:2000 dilution of alikely that, as for other neurotrophic factors tested using
peroxidase-linked donkey anti-rabbit antibody. Following incuba-this model (Vejsada et al., 1995; R. V. and A. K., unpub-
tion in the second antibody for 1 hr the filters were washed anlished data), more durable effects will be obtained by
additional three times with PBS containing Tween 20 before detec-the use of combinations of neurotrophic factors and of
tion of the antigen using standard ECL (Boehringer).
improved methods of delivery.
In conclusion, cardiotrophin-1, originally identified for
Preparation of Affinity-Purified CT-1 Antibodyits effects on hypertrophy of cardiac myocytes, has ef-
We mixed 4.4 mg of dialyzed and concentrated CT-1 with controlledfects on motoneurons in vitro and in vivo that are of
pore glass (CPG) glyceryl affinity resin (Sigma) for 24 hr at 48C inpotential importance in understanding the normal devel-
the presence of NaBH3CN (to stabilize the binding of CT-1 to the
opment of the motor unit and in attempting to reduce resin). The resin was washed several times with 0.05 M sodium
motoneuron loss in human neurodegenerative disease. carbonate (pH 8.5) and mixed with NaBH3CN and 1 M ethanolamine
(to block unbound sites) for 24 hr at 48C. This treated resin was then
packed into an FPLC column. The column was preeluted with 0.1Experimental Procedures
M Na-acetate (pH 2.8), followed by equilibration with load buffer
(PBS, 0.5 M NaCl). Rabbit antiserum to CT-1 was sterile filtered andIn Situ Hybridization
Mouse E13.5 embryos were immersion-fixed overnight at 48C in applied to the column at a flow rate of 2.0 ml/min. The nonspecific
proteins were washed off the column with load buffer, and the CT-4% paraformaldehyde and then cryoprotected overnight in 15%
sucrose. Sections (16 mm) were processed for in situ hybridization 1-specific antibodies were eluted as 0.5 ml fractions with 0.1 M Na-
acetate (pH 2.8). The final antibody preparation was either sterilefor CT-1 by a modification of the method previously described (Phil-
lips et al., 1990). [33P]UTP-labeled RNA probes were generated as filtered or stored with 0.01% thimerosal.
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Motoneuron Purification and Culture Histology and Motoneuron Counting
At the indicated survival times, rats were sacrificed by an overdoseSpinal motoneurons were purified from ventral spinal cords of E14
rat embryos essentially as described (Henderson et al., 1995). In of phenobarbital. Following transcardiac perfusion with 4% para-
formaldehyde in PBS, the lumbosacral spinal cord was removed,brief, cells were dissociated after trypsin treatment and centrifuged
over a 6.5% metrizamide cushion. The large cells remaining above cryoprotected in sucrose-PBS solutions, and sectioned (30 mm) on
a cryostat. Serial sectionswere cover-slipped with Eukitt andviewedthe cushion were further fractionated by immunopanning on dishes
coated with the 192 antibody (Chandler et al., 1984), which recog- under a Reichert–Jung fluorescent microscope with a UV filter at
1253 to 2003 magnification. Fluorogold-labeled sciatic motoneu-nizes the low affinity NGF receptor and is specific to motoneurons
at this age (Yan and Johnson, 1988). Contaminating cells were re- rons were localized in the ventral horn of spinal segments from
caudal L3 through to cranial L6. Profiles of labeled cells weremoved by washing and specifically boundmotoneurons eluted using
an excess of 192 antibody. Purified motoneurons were collected counted on each section (i.e., 90–120 sections per cord, depending
on the age); no correction factor was applied to the counts. Theby centrifugation through a bovine serum albumin (BSA) cushion.
Typical yields were 10,000 large motoneurons per E14 spinal cord. values shown are means 6 SEMs from at least three animals.
No exact figures are available for the total number of motoneurons
in embryonic rodent spinal cord, but one lumbar motor column in Preparation of Soluble CNTFR
neonatal mice contains on the order of 3000 motoneurons (DeChiara The cDNA coding for the CNTFRa subunit was generated from E14
et al., 1995; Li et al., 1995b), suggesting that the total number may mouse brain by RT–PCR. PCR primers were designed to truncate
not be far in excess of 25,000. the amino acid sequence before the GPI linkage site (amino acids
Purified motoneurons were seeded in dishes coated with polyor- 1–335) and a C-terminal tag encoding six histidine residues was
nithine–laminin (1500–2000 per 35 mm dish; 1000 per 16 mm well). added. Sequencing of the cDNAin the mammalian expressionvector
Culture medium (“basal medium”) was Neurobasal (GIBCO-BRL), pRK5 (Suva et al., 1987) confirmed the sequence was correct. The
supplemented with the B27 supplement (GIBCO-BRL), horse serum expression plasmid was transfected into 293 cells and after 4 days
(2% v/v), L-glutamine (0.5 mM), and 2-mercaptoethanol (25 mM). the conditioned medium was concentrated 20-fold (Centriprep 10,
L-glutamate (25 mM) was added to the medium for the first 4 days Amicon). The tagged protein was isolated by Ni21–nitrilo–triacetic
of culture and subsequently omitted. Subsequently, every 4–5 days, acid–agarose (QIAGEN) as described (Pennica et al., 1995a).
1.5 ml of medium was removed and replaced with 1.5 ml fresh
medium containing sufficient quantities of the indicated neuro- Myocyte Hypertrophy Assay
trophic factor to supplement the 2 ml of medium in the dish. For Substances were tested as described previously (Pennica et al.,
longer term cultures, precautions were taken to maintain high hu- 1995a). In brief, hearts were excised from 1-day-old Sprague–
midity, so as to prevent concentration of medium components by Dawley rats. Ventricular cardiac myocytes were isolated by colla-
evaporation. genase digestion and Percoll gradient purification. The myocytes
were diluted into serum-free DMEM/F12 supplemented with 10 mg/
Quantification of Motoneuron Survival in Culture ml transferrin, 1 mg/ml insulin, 1 mg/ml aprotinin, 2 mM glutamine,
Motoneuron survival was quantified by direct counting under phase- 100 U/ml penicillin G, and 100 mg/ml streptomycin and plated at a
contrast in a predetermined area of 1.5 mm2 in the center of the final density of 1.5 3 104 cells per well of a 96-well flat-bottomed
dish. All motoneurons that appeared alive by phase-contrast also plate previously coated with 10% fetal calf serum in DMEM/F12.
were labeled by the vital dye AM-calcein (data not shown). Initial After 24 hr at 378C, test substances were added. After 2 days, the
attachment of motoneurons was identical in all conditions. To com- cells were fixed and stained with 0.5% crystal violet. The hypertro-
pare data from different experiments in a quantitative manner, the phy score was assessed on a scale of 1 to 7 by microscopic evalua-
number of motoneurons that developed initially in the presence of tion. The increase in myocyte cell size, expressed as hypertrophy
100 pg/ml GDNF was determined by counting neurons with neu- score, is dose-dependent and is accompanied by an increase in
rites >4 cell diameters in length after 16 hr of culture. Unless other- atrial natriuretic peptide production. Untreated cells are scored as
wise indicated, this figure was taken as 100% survival. At later 3. Toxic effects are scored from 0–2. A score of 7 indicates maximal
stages, only large Islet-positive neurons with long axon-like pro- hypertrophy such as that induced by 0.1 mM phenylephrine.
cesses (>80% of cells present) were counted. The small motoneu-
rons we have described (Henderson et al., 1993b) were rare or Binding Assays
absent in these conditions and in general did not survive in long- Mouse CT-1 and rat CNTF (R&D Systems) were iodinated as de-
term cultures. scribed (Pennica et al., 1995b) to specific activities of 1000 Ci/mmol
and 750 Ci/mmol, respectively, using Enzymobeads (Bio-Rad). For
Immunofluorescence Labeling of Cultured Motoneurons binding assays, 0.14 nM 125I-labeled rat CNTF and 0.09 nM 125I-
Motoneurons were fixed using 4% paraformaldehyde, 0.1% glutaral- labeled CT-1 were used. Cells were incubated in a 150 ml volume
dehyde in PBS at 48C for 30 min and then washed. After quenching of with gentle agitation in the presence of iodinated ligand in the pres-
excessaldehyde groups with 50 mM lysine, cells were permeabilized ence or absence of 100 nM of unlabeled competitor for 2 hr at room
using 0.1% Triton X-100, and nonspecific binding sites were blocked temperature. Unbound counts were removed from the cell pellets
by incubation for 2 hr with PBS containing horse serum (10% v/v) by two washes with ice-cold PBS with 0.1% BSA and the pellets
and BSA (2% w/v). Subsequently, first antibody was added at the counted in a gamma counter (Isodata)
indicated dilution and allowed to bind overnight at 48C. After wash-
ing, dishes were treated with appropriate secondary antibodies Acknowledgments
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